Company Analysis

TransMedics Group, Inc. (TMDX)

Nasdaq: TMDX · Electromedical & Electrotherapeutic Apparatus · Andover, MA · filing with the SEC since 2018
Grade7.2
◀ Past 7.1● Present 7.2▶ Future 7.1

The company now

TransMedics Group, Inc. is classed by the SEC under Electromedical & Electrotherapeutic Apparatus (industry code 3845), based in Andover, MA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $605 million and a profit of $190 million (its filed statements).

From its filings and filed figures; the desk's account of it is not written yet.

Where the revenue comes from

fiscal 2025, as filed

Revenue by product, fiscal 2025

ProductFiscal 2025Fiscal 2024Share of revenue
Product$372M$274M61.1%
Service$233M$168M38.2%
Service Unrelated to OCS Transplant$4.1M$4.4M0.7%

As tagged in its annual report (Form 10-K, filed Feb 24, 2026 ↗), read from the SEC's financial statement data sets. The year before is the figure the record holds for the prior fiscal year.

The desk's written account of this company, its Past, Present and Future, is not on file yet.

How the company works

The desk has not read this company's annual report yet.

The record in brief

The desk has not written this company's report yet.

SI Assistanton TMDX · research, not advice